News

Range Impact Takes Steps to Enhance Visibility with OTCQB Uplist

Range Impact Takes Steps to Enhance Visibility with OTCQB Uplist

Range Impact Moves Forward with OTCQB Application

Range Impact, Inc. (OTC: RNGE) is excited to announce that it has applied to uplift its common shares from the OTC Pink Sheets to the OTCQB Venture Market. This decision marks an important step for the company, with the goal of boosting engagement with shareholders and extending its presence in the market.

Understanding the OTCQB Venture Market

The OTCQB Venture Market is recognized as a trading venue specifically designed for entrepreneurial and growth-focused companies. According to the Securities and Exchange Commission, it functions as a recognized public market that helps determine the public market price for securities. This uplisting is viewed as a crucial initiative by Range Impact's leadership to enhance its standing within the investment community.

Insights from the CEO

Michael Cavanaugh, the CEO of Range Impact, expressed his excitement regarding this development, stating, "We believe that uplisting to the OTCQB would broaden the Company's shareholder base and enhance the Company's visibility and transparency within the investment community." The anticipated approval of this application is seen as a significant opportunity to access capital more easily, which, in turn, creates more attractive trading options for investors.

Application Review Process

After submitting its uplist application, Range Impact is ready to work closely with the OTC Markets Group Inc. for a comprehensive review process. This transparent approach ensures that all stakeholders are kept informed about how the application is progressing. If successful, Range Impact expects its common stock to continue trading under the ticker symbol "RNGE" on the OTCQB platform.

Commitment to Impact Investing

Range Impact is on a mission to improve health and wellness for communities and the environment through innovative impact investing. Headquartered in Cleveland, Ohio, the company runs multiple businesses aimed at creating long-term solutions to environmental, social, and health-related challenges. A key part of its strategy involves acquiring, reclaiming, and repurposing undervalued land, particularly in economically distressed areas throughout Appalachia.

Strategic Vision

Utilizing its unique competitive advantages, Range Impact takes a distinctive approach to tackling traditional problems. This approach inspires the company to judiciously invest its resources into opportunities that yield positive impacts while also providing solid returns for its shareholders.

Engaging with Investors

As Range Impact progresses on its journey toward uplisting, it remains dedicated to fostering open communication with its investor base. This engagement is crucial as it builds trust and ensures that investors stay updated on the company's initiatives and growth path.

Frequently Asked Questions

What does uplisting to the OTCQB mean for Range Impact?

Uplisting to the OTCQB indicates Range Impact's potential for growth and increases its visibility and credibility among investors.

How will this affect investors in RNGE?

Investors can anticipate better access to capital and potentially improved trading opportunities, which could lead to increased shareholder value.

What is the focus of Range Impact's business strategy?

Range Impact emphasizes impact investing, working on reclaiming undervalued properties to effectively tackle social and environmental challenges.

How does Range Impact keep investors updated?

The company is committed to keeping its investors in the loop about the status of its uplisting application and other important developments.

What is the next step after submitting the application?

The next step involves the review of the application by the OTC Markets Group, and Range Impact will ensure stakeholders are informed throughout the process.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Claigan Webinar Tackles Prop 65 Warnings for 2028

Updated Category News Views 26

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Continue Reading
Understanding Voting Rights and Corporate Governance at Valeo

Updated Category News Views 54

Understanding Voting Rights and Corporate Governance at Valeo Valeo, a prominent name in the mobility technology sector, plays an essential role in implementing innovative solutions that contribute to cleaner, safer, and smarter transportation. As a technology partner to automakers and emerging players in the mobility space, the company's advancements are vital for the...

Continue Reading
Transforming Field Service Management Through Strategic Alliances

Updated Category News Views 101

ServicePower and Marcone Appliance Parts Form Strategic Alliance In a notable development, ServicePower, a recognized leader in field service management software, has announced a strategic partnership with Marcone Appliance Parts, a well-established distributor in North America. This collaboration aims to revolutionize how service providers operate by integrating...

Continue Reading
Goldman Sachs Pushes Gold Price Target to Mid-2026

Updated Category News Views 639

Goldman Sachs Updates Gold Price Forecast Goldman Sachs has recently adjusted its predictions on gold prices, extending the expected timeline for reaching $3,000 per ounce to mid-2026. This update signals a significant shift from earlier forecasts that anticipated this milestone as early as December 2025. Factors Influencing the Price Revision The primary reason for this...

Continue Reading
Comcast's Generous $50,000 Donation for Storm Relief Efforts

Updated Category News Views 213

Comcast's Commitment to Community Support Comcast has recently made a poignant statement of support by donating $50,000 to assist nonprofit organizations as they work to aid those affected by destructive storms. This financially targeted initiative is designed to ensure families and businesses get the vital resources they require during challenging times. Donation Purpose...

Continue Reading